HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

FDA is leading research to understand how images, music, and other elements of direct-to-consumer advertising affect consumer understanding and retention of the risks and benefits of […]

On This Page Date: November 9, 2023 Time: 8:00 AM – 4:45 PM ET About The meeting will be held as a hybrid event, hosted from […]

CPG Sec. 440.100 Marketed New Drugs Without Approved NDAs and ANDAs 09/21/2011 11/25/2020   Policy for Certain REMS Requirements During the COVID-19 Public Health Emergency Guidance […]

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs) subject to priority review […]

R. Angelo de Claro is a hematology-oncology physician and currently the Associate Director (Acting) for Global Clinical Sciences with the Oncology Center of Excellence. In this […]

[embedded content] Español Sun safety is always in season. It’s important to protect your skin from sun damage throughout the year, no matter the weather. Why? […]

[embedded content] Español When you go outdoors with your infant, whether for a quick stroll in the park or a day at the beach, it’s important […]